Hepatocellular adenoma and polycystic ovary syndrome.
Various identified risk factors predispose to hepatocellular adenomas. We present the case of a young woman with liver adenoma in a context of polycystic ovary syndrome, associated with high levels of androgens and following a high dose hormonal therapy. In view of this complication, we recommend a close screening of patients with such hormonal imbalance, especially those who are treated with high doses of hormones, with repeated liver tests and ultrasonographies.
Toso
Christian
C
Clinique et Policlinique de Chirurgie digestive, Département de chirurgie, Hôpitaux Universitaires Genève, Rue Michelidu-Crest, 24 CH-1211, Genève. christian.toso@hcuge.ch
Rubbia-Brandt
Laura
L
Negro
Francesco
F
Morel
Philippe
P
Mentha
Gilles
G
D018248:Adenoma, Liver Cell / Q000139:chemically induced* / Q000175:diagnosis; D000328:Adult; D004958:Estradiol / Q000009:adverse effects* / Q000031:analogs & derivatives*; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000175:diagnosis; D009644:Norgestrel / Q000009:adverse effects*; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000188:drug therapy*; D045167:Progesterone Congeners / Q000009:adverse effects* / Q000627:therapeutic use
D004966:Estrogens, Conjugated (USP); D045167:Progesterone Congeners; D009644:Norgestrel; D004958:Estradiol